PIRML ENT Share Price

PEL

INE140A01024

Last Transcript: PIRML ENT

Piramal Enterprises Limited, Q2 2026 Earnings Call, Oct 17, 2025

17/10

More transcripts

Analysts' recommendations: PIRML ENT

20/10	Jefferies Adjusts Piramal Enterprises' Price Target to INR1,015 From INR1,000, Keeps at Underperform	MT
30/07	Jefferies Adjusts Piramal Enterprises' Price Target to INR1,000 From INR835, Keeps at Underperform	MT
07/05	Jefferies Adjusts Piramal Enterprises' Price Target to INR835 From INR811, Keeps at Underperform	MT
28/01	Jefferies Adjusts Piramal Enterprises' Price Target to INR811 From INR820, Keeps at Underperform	MT
24/24/24	Jefferies Adjusts Piramal Enterprises' Price Target to INR820 From INR805, Keeps at Underperform	MT

More recommendations

Managers and Directors: PIRML ENT

Manager	Title	Age	Since
Rupen Jhaveri PSD	President	-	01/12/2021
Jitendra Bhati CMP	Compliance Officer	-	02/06/2025
Viral Gandhi CTO	Chief Tech/Sci/R&D Officer	51	-

Director	Title	Age	Since
Ajay Gopikisan Piramal CHM	Chairman	70	-
Swati Ajay Piramal BRD	Director/Board Member	69	14/10/2011
Nandini Ajay Piramal BRD	Director/Board Member	44	01/04/2009

More insiders

Piramal Enterprises Ltd. is an India-based diversified non-banking financial company, with a presence across retail lending, wholesale lending, and fund-based platforms. The Company is engaged in providing finance. Its businesses include retail lending, wholesale lending, Piramal Alternatives and life insurance. In retail lending, the Company offers multiple products, including housing loans, loan against property, used car loans, small business loans, personal loans and microfinance. In wholesale lending, it caters to both real estate and non-real estate sectors, offering multiple products including construction finance, structured debt and senior debt to diverse corporate clients. Piramal Alternatives is the fund management business of the Piramal Group and an institutional capital provider in India. It has an approximately 50% stake in Pramerica Life Insurance. Pramerica Life Insurance provides a range of life insurance solutions for individuals as well as groups.

Employees

16,035

Sector

More about the company

30/10	Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding Its Payload-Linker Platform and Bioconjugate Capabilities	CI
20/10	Jefferies Adjusts Piramal Enterprises' Price Target to INR1,015 From INR1,000, Keeps at Underperform	MT
17/10	Piramal Enterprises Limited, Q2 2026 Earnings Call, Oct 17, 2025
19/09	Piramal Enterprises Limited Announces Resignation of Upma Goel as Key Managerial Personnel, with Effect from September 30, 2025	CI
19/09	Piramal Enterprises Limited Announces Resignation of Upma Goel as Chief Financial Officer, with Effect from September 30, 2025	CI
10/09	India New Issue-Piramal Finance to issue near 3-year bonds, bankers say	RE
30/07	Jefferies Adjusts Piramal Enterprises' Price Target to INR1,000 From INR835, Keeps at Underperform	MT
30/07	Piramal Enterprises Limited, Q1 2026 Earnings Call, Jul 29, 2025
29/07	Piramal Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
29/07	Piramal Enterprises' CFO Resigns; Vikash Singhla to Take Over Post-Merger	MT
29/07	Piramal Enterprises June-quarter consol profit 2.76 billion rupees	RE
21/07	Piramal Enterprises to consider fund raising	RE
30/06	Piramal Enterprises Limited Approves Final Dividend for the Financial Year Ended March 31, 2025	CI

07/05	Piramal Enterprises : Announces Consolidated Results for Q4 and Full Year FY25	PU
29/04	Piramal Enterprises : Alternatives Invests INR 160 Cr in Saimirra Innopharm Pvt. Ltd	PU
08/04	Piramal Enterprises : Finance and ICICI Bank Join Hands for Co-Lending Partnership	PU
03/04	Piramal Enterprises : Finance Raises USD 265 Million via External Commercial Borrowing	PU
18/03	Piramal Enterprises : Finance Partners with Punjab & Sind Bank to Boost Lending in Semi-Urban & Rural Areas	PU

1 day	+0.25%
3 months	-1.10%
6 months	+11.05%
Current year	+1.88%

Current year	849.9	1,355.9
1 year	849.9	1,355.9
3 years	630.2	1,355.9
5 years	630.2	3,013
10 years	608	3,302.55

PIRML ENT Share Price

Equities

PEL

INE140A01024

Chart: PIRML ENT

Latest news: PIRML ENT

Last Transcript: PIRML ENT

Analysts' recommendations: PIRML ENT

Press Releases: PIRML ENT

Quotes and Performance

Course Extremes

Managers and Directors: PIRML ENT

ETFs: PIRML ENT

Company Profile